These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2129309)

  • 1. [Branhamella catarrhalis respiratory tract infections].
    Letonja S; Music E; Kumelj M
    Plucne Bolesti; 1990; 42(3-4):144-7. PubMed ID: 2129309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respiratory infections caused by Branhamella catarrhalis in 5 different hospitals].
    Matsumoto K; Nakayama T; Rikitomi N; Yoshida T; Oishi K; Takahashi A; Tanaka H; Suzuki H; Nagatake T; Ide M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):448-56. PubMed ID: 2120497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of Moraxella catarrhalis in patients with respiratory tract infections].
    Jakubicz P; Leszczyńska K
    Med Dosw Mikrobiol; 1997; 49(1-2):55-60. PubMed ID: 9411073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory tract infections due to Branhamella catarrhalis and Neisseria species.
    McGowan JE
    Curr Clin Top Infect Dis; 1987; 8():181-203. PubMed ID: 3151758
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients.
    Tamang MD; Dey S; Makaju RK; Jha BK; Shivananda PG; Bhramadatan KN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):39-44. PubMed ID: 16401943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.
    Babay HA
    Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella catarrhalis in respiratory infections].
    Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
    Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G; Denamur E; Laurans G; Orfila J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens].
    Ruckdeschel G
    Fortschr Med; 1994 Nov; 112(33):485-8. PubMed ID: 7843673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Branhamella catarrhalis: its respiratory pathogenicity in childhood].
    Moreno Galdo A; Ferrer Marcelles A; Aizpurúa Galdeano P; Navarro Aguirre M; Fernández Pérez F; Iglesias Berengue J
    An Esp Pediatr; 1990 Aug; 33(2):135-9. PubMed ID: 2125809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance, isolation, identification and sensitivity of Branhaemella (moraxella) catarrhalis.
    Hafiz S; Hafiz T; Yazdani I
    J Pak Med Assoc; 1993 Aug; 43(8):153-4. PubMed ID: 8264093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.